| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Arcus Biosciences, Inc. (RCUS) has 7 insiders with recent SEC Form 4 filings, including 22 buys and 0 sells. RCUS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 2.16M | $61.12M | - | |
| Pres | 822.5K | $23.30M | -68,569 | |
| COO | 193.0K | $5.47M | - | |
| Other | 124.7K | $3.53M | - | |
| CFO | 67.9K | $1.92M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 12, 2019 | Falberg Kathryn E53 | Director | Buy | 20,000 | $8.20 | $163,928.00 | +18.5% | |
| Jun 10, 2019 | Falberg Kathryn E53 | Director | Buy | 32,065 | $8.07 | $258,797.14 | +57.0% | |
| Jun 6, 2019 | Rosen Terry J72 | Chief Executive Officer | Buy | 21,738 | $7.93 | $172,344.16 | +0.4% | |
| Jun 4, 2019 | Rosen Terry J72 | Chief Executive Officer | Buy | 41,540 | $7.91 | $328,575.17 | +0.7% | |
| Jun 3, 2019 | Jaen Juan C.75 | President | Buy | 10,000 | $8.25 | $82,485.00 | +0.4% | |
| Nov 13, 2018 | Jaen Juan C.75 | President | Buy | 10,000 | $11.80 | $118,039.00 | +0.4% | |
| Aug 28, 2018 | Rosen Terry J72 | Chief Executive Officer | Buy | 18,607 | $15.07 | $280,431.11 | +0.2% | |
| Aug 24, 2018 | Rosen Terry J72 | Chief Executive Officer | Buy | 9,289 | $13.45 | $124,940.03 | - | |
| Aug 21, 2018 | Rosen Terry J72 | Chief Executive Officer | Buy | 8,891 | $13.24 | $117,727.01 | - | |
| Aug 16, 2018 | Rosen Terry J72 | Chief Executive Officer | Buy | 28,401 | $12.64 | $359,127.35 | +0.2% |